The combination of targeted therapies and immunotherapy are the future for patients with advanced thyroid cancer Published on 19/09/2022 The new approach for the advanced stages of the disease incorporates immunotherapy to treatment, with the aim of maintaining the benefits of targeted therapies for the patient over time